Should we stop using intravenous gentamicin in patients with cystic fibrosis?

Goss, Christopher H.
June 2008
Thorax;Jun2008, Vol. 63 Issue 6, p479
Academic Journal
The article discusses various reports published within the issue including one by A. Smith on the case-control study of acute renal failure in patients with cystic fibrosis and another by M. Al-Aloul on renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use.


Related Articles

  • Aminoglycosides linked to acute renal failure in CF patients.  // Reactions Weekly;8/11/2007, Issue 1164, p3 

    The article discusses the results of a survey of acute renal failure (ARF) in patients with cystic fibrosis (CF) in Great Britain. The survey found that ARF in patients with CF implicate IV aminoglycosides as an etiological factor. Based on responses, 55 cases were identified with consent given...

  • Case-control study of acute renal failure in patients with cystic fibrosis in the UK.  // Current Medical Literature: Respiratory Medicine;2008, Vol. 22 Issue 3, p75 

    The article discusses research being done on the association between treatment of cystic fibrosis (CF) with intravenous gentamicin and an increased risk of acute renal failure (ARF). It references a study by A. Smyth et al which appeared in a 2008 issue of "Thorax." Results showed that the use...

  • Case-control study of acute renal failure in patients with cystic fibrosis in the UK. Smyth, A.; Lewis, S.; Bertenshaw, C.; Choonara, I.; McGaw, J.; Watson, A. // Thorax;Jun2008, Vol. 63 Issue 6, p532 

    Background: There has been a recent increase in the number of reported cases of acute renal failure (ARE) in cystic fibrosis (CE). A case-control study was conducted to determine the factors which are associated with an increased risk of ARF. Methods: 24 cases of confirmed ARF were identified in...

  • An infant with alternating metabolic acidosis and alkalosis: answer. Hooman, Nakysa; Jafari, Daniel; Jalali-Farahani, Sahar; Lahouti Harahdashti, Arash // Pediatric Nephrology;Jan2012, Vol. 27 Issue 1, p53 

    The article presents answers to a quiz on a case study of an infant with alternating metabolic acidosis and alkalosis.

  • In vitro modulation of tubular cyst regression in murine polycystic kidney disease. Avner, Ellis D.; Sweeney, Jr., William E.; Ellis, Demetrius // Kidney International;Dec1989, Vol. 36 Issue 6, p960 

    Recent studies in a murine model of genetically-determined polycystic kidney disease, the CPK mouse, have suggested that alterations in renal Na-K ATPase activity in concert with tubular epithelial hyperplasia have pathogenic import in proximal tubular cysi formation. In the current study, we...

  • Prerenal azotemia from excessive sweating in an adult with a cystic fibrosis gene mutation. Tomov, S. V.; Flume, P. A.; Stenbit, A. E.; Ullian, M. E. // Indian Journal of Nephrology;Jul-Sep2011, Vol. 21 Issue 3, p194 

    We present the case of a 58-year-old male with chronic kidney disease who was admitted to the hospital multiple times with extracellular fluid volume depletion and prerenal azotemia. Some episodes were associated with gastrointestinal fluid losses and others with profuse diaphoresis in the...

  • Cystic fibrosis, aminoglycoside treatment and acute renal failure: the not so gentle micin. Bockenhauer, Detlef; Hug, Martin J.; Kleta, Robert // Pediatric Nephrology;May2009, Vol. 24 Issue 5, p925 

    Aminoglycosides have a wide spectrum of gram-negative anti-bacterial activities and are available at low cost, which makes them commonly used drugs, especially for patients with cystic fibrosis (CF), who often suffer from chronic lung infections from Pseudomonas aeruginosa. Unfortunately, this...

  • Acute renal failure in cystic fibrosis.  // Archives of Disease in Childhood;Oct2007, Vol. 92 Issue 10, p915 

    The article offers information on the study conducted by the Great Britain cystic fibrosis centers on acute renal failure in patients with cystic fibrosis. The study assesses about 55 possible cases of acute renal failure between 1997 and 2004. This study estimated that the incidence was...

  • Are Elevated Vancomycin Serum Trough Concentrations Achieved Within the First 7 Days of Therapy Associated With Acute Kidney Injury in Children? Knoderer, Chad A.; Nichols, Kristen R.; Lyon, Kelsey C.; Veverka, Megan M.; Wilson, Amy C. // Journal of the Pediatric Infectious Diseases Society;Jun2014, Vol. 3 Issue 2, p127 

    Background In 2008, the empiric vancomycin dosing recommendation in children at our institution was changed from 40 to 60 mg/kg per day. Subsequently, an increased incidence of acute kidney injury (AKI) in patients receiving vancomycin was suspected. The objective of this study was to evaluate...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics